This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Expansions latest in series of additions to global dedicated healthcare networkMISSISSAUGA, ON,
Feb. 5, 2013 /CNW/ - UPS (NYSE: UPS) today announced a significant expansion of its global healthcare distribution network in five key markets in
North America. Expanding locations include facilities in
Mira Loma, Calif.,
Atlanta, Ga., and
Reno, Nev. The new expansions add nearly 800,000 square feet (sq.ft.) to UPS's global network of 37 dedicated healthcare facilities, which now total nearly six million sq. ft. of distribution space.
This investment represents the most recent installment of UPS's ongoing commitment to serve the distinctive needs of healthcare clients around the world. UPS announced the expansion of its healthcare distribution network in the
Asia- Pacific region in
October 2012, with the opening of three new facilities in
Shanghai, China and
Several industry trends are driving the expansion of UPS's global healthcare network, including increasing globalization, complex regulatory oversight, heightened focus on outcomes and a growing need for specialized healthcare services, such as temperature-sensitive solutions. The latest expansions were driven by the growth of UPS's healthcare customers and the UPS global healthcare strategy that supports customers as they grow and adapt to these trends.
"UPS is committed to investing in our global network and supporting industry demand to meet customer needs for increased speed, flexibility and efficiency," said
Bill Hook, vice-president, global strategy, UPS Healthcare Logistics. "Our healthcare customers are creating value through our broad network and single global technology platform."
UPS facilities meet all applicable government accreditations, licences and maintain geographic-specific regulatory requirements, such as those of the Food and Drug Administration (FDA), Drug Enforcement Agency (DEA) and Health Canada, among hundreds of others.